Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Burrows

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cellular Immunology|April 15, 1990
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
The Journal of General Virology|September 1, 1994
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3S R Burrows, J Gardner, R Khanna, et al.
Nature|February 25, 1988
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsD J Moss, I S Misko, S R Burrows, et al.
Journal of Virology|April 1, 1996
Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolutionJ M Burrows, S R Burrows, L M Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine designS A Thomson, R Khanna, J Gardner, et al.
Cancer Research|January 27, 1998
Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cellsR Khanna, P Busson, S R Burrows, et al.
Immunity|June 10, 1998
HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loadingC A Peh, S R Burrows, M Barnden, et al.
International Immunology|November 14, 1997
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processingR Khanna, S R Burrows, P M Steigerwald-Mullen, et al.
The Journal of Experimental Medicine|December 1, 1995
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenS R Burrows, S L Silins, D J Moss, et al.
Journal of Virology|July 1, 1996
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequencesJ M Burrows, R Khanna, T B Sculley, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cellular Immunology|April 15, 1990
Patterns of reactivity of Epstein-Barr virus-specific T cells in A-type donor cultures after reactivation with autologous A- or B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
The Journal of General Virology|September 1, 1994
Five new cytotoxic T cell epitopes identified within Epstein-Barr virus nuclear antigen 3S R Burrows, J Gardner, R Khanna, et al.
Nature|February 25, 1988
Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformantsD J Moss, I S Misko, S R Burrows, et al.
Journal of Virology|April 1, 1996
Unusually high frequency of Epstein-Barr virus genetic variants in Papua New Guinea that can escape cytotoxic T-cell recognition: implications for virus evolutionJ M Burrows, S R Burrows, L M Poulsen, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 20, 1995
Minimal epitopes expressed in a recombinant polyepitope protein are processed and presented to CD8+ cytotoxic T cells: implications for vaccine designS A Thomson, R Khanna, J Gardner, et al.
Cancer Research|January 27, 1998
Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cellsR Khanna, P Busson, S R Burrows, et al.
Immunity|June 10, 1998
HLA-B27-restricted antigen presentation in the absence of tapasin reveals polymorphism in mechanisms of HLA class I peptide loadingC A Peh, S R Burrows, M Barnden, et al.
International Immunology|November 14, 1997
Targeting Epstein-Barr virus nuclear antigen 1 (EBNA1) through the class II pathway restores immune recognition by EBNA1-specific cytotoxic T lymphocytes: evidence for HLA-DM-independent processingR Khanna, S R Burrows, P M Steigerwald-Mullen, et al.
The Journal of Experimental Medicine|December 1, 1995
T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigenS R Burrows, S L Silins, D J Moss, et al.
Journal of Virology|July 1, 1996
Identification of a naturally occurring recombinant Epstein-Barr virus isolate from New Guinea that encodes both type 1 and type 2 nuclear antigen sequencesJ M Burrows, R Khanna, T B Sculley, et al.
Pageof 8